Basappa Basappa
Overview
Explore the profile of Basappa Basappa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen S, Zhang X, Basappa B, Zhu T, Pandey V, Lobie P
Commun Med (Lond)
. 2025 Feb;
5(1):45.
PMID: 39984660
Background: Tumor dormancy is a substantial clinical obstacle in treatment of estrogen receptor positive mammary carcinoma (ER+MC), contributing to drug resistance, metastatic outgrowth, relapse, and consequent mortality. Methods: Preclinical models...
2.
He C, Wang X, Chiou Y, Basappa B, Zhu T, Pandey V, et al.
Cell Death Dis
. 2025 Feb;
16(1):76.
PMID: 39920140
The interaction between HER2 and ERα signaling pathways contributes to resistance to anti-estrogen and HER2-targeted therapies, presenting substantial treatment challenges in ER-positive (ER+) HER2-positive (HER2+) mammary carcinoma (MC). Trefoil Factor-3...
3.
Siddappa T, Ravish A, Xi Z, Mohan A, Girimanchanaika S, Krishnamurthy N, et al.
ACS Omega
. 2025 Jan;
10(1):114-126.
PMID: 39829533
STAT3 has emerged as a validated target in cancer, being functionally associated with breast cancer (BC) development, growth, resistance to chemotherapy, metastasis, and evasion of immune surveillance. Previously, a series...
4.
Zhang S, Tan Y, Zhang X, Basappa B, Zhu T, Pandey V, et al.
Oncogene
. 2024 Dec;
44(11):753-768.
PMID: 39658649
Intrinsic and acquired resistance represent major obstacles to optimize outcomes in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) targeted therapy in lung adenocarcinoma (LUAD). Hence, a deeper understanding...
5.
Sankova M, Beeraka N, Oganesyan M, Rizaeva N, Sankov A, Shelestova O, et al.
J Orthop Translat
. 2024 Nov;
49:289-307.
PMID: 39559294
Background: In recent years, many countries have actively implemented programs and strategies to promote physical education and sports. Despite these efforts, the increase in physical activity has been accompanied by...
6.
Xinyi Y, Vladimirovich R, Beeraka N, Satyavathi A, Kamble D, Nikolenko V, et al.
Stem Cell Res Ther
. 2024 Nov;
15(1):401.
PMID: 39506818
Background: Hematopoiesis within the bone marrow (BM) is a complex and tightly regulated process predominantly influenced by immune factors. Aging, diabetes, and obesity are significant contributors to BM niche damage,...
7.
Kim N, Vishwanath D, Basappa S, Kumar Harish K, Madegowda M, Rangappa K, et al.
Chem Biol Interact
. 2024 Oct;
404:111285.
PMID: 39442680
β-catenin is frequently implicated in signaling pathways that regulate autophagy, and the production of reactive oxygen species (ROS) has been linked to autophagy activation. Isoxazole-based nucleoside compounds have demonstrated anti-cancer...
8.
Yuan J, Yang L, Li Z, Zhang H, Wang Q, Wang B, et al.
IUBMB Life
. 2024 Sep;
76(12):1309-1324.
PMID: 39275910
Several chemotherapeutics against breast cancer are constrained by their adverse effects and chemoresistance. The development of novel chemotherapeutics to target metastatic breast cancer can bring effective clinical outcomes. Many breast...
9.
Yoon B, Basappa B, Basappa S, Nagaraju O, Madegowda M, Rangappa K, et al.
IUBMB Life
. 2024 Sep;
76(12):1377-1391.
PMID: 39257214
Autophagy is vital for maintaining cellular homeostasis by breaking down unnecessary organelles and proteins within cells. Its activity varies abnormally in several diseases, including cancer, making it a potential target...
10.
Wang L, Zhang X, Chen S, Ye Q, Basappa B, Zhu T, et al.
Transl Oncol
. 2024 Aug;
49:102103.
PMID: 39181117
Objective: Mitomycin C (MMC), a DNA-damaging chemotherapeutic, is commonly used clinically for recurrent cervical carcinoma (CC), either alone or in combination. MMC generates DNA damage resulting in CC cell death...